Meg Terrell
Showing 1–2 of 2 transcripts.
- Milken Institute1h 2m
In Search for a Cure: Are We Nearing a Treatment for COVID-19?
Esther Kofa, Meg Terrell, Dr. Tony Fauci, Albert Bourla
The Milken Institute Summer Series concluded by analyzing the U.S. resurgence of COVID-19 infections and the global development of nearly 250 treatment compounds, featuring critical insights from Dr. Anthony Fauci and Pfizer CEO Dr. Albert Bourla. Dr. Fauci warned of severe fall surges driven by behavioral shifts while outlining a vaccine timeline with Phase III trials expected to begin in July, whereas Dr. Bourla detailed Pfizer's autonomous mRNA strategy aiming for safety and efficacy data by September. As the organization prepares its 23rd Global Conference for a likely online format in October, these discussions underscored the urgent need for robust public health protocols alongside rapid medical solutions.
- Milken Institute1h 5m
The Future of Brain Health
Maxine Waters, Michael Clowden, Meg Terrell, Dr. Ruth Benka, Dr. Marie Bernard, Dr. Rod Hockman, Nora Super, Dr. Rudy Tanzi
Congresswoman Maxine Waters secured bipartisan backing from 130 legislators for a proposed $2.65 billion Alzheimer's research budget, aiming to meet the 2025 national goal of a cure while addressing the projected bankruptcy of the U.S. healthcare system. Parallel scientific advances, including Biogen's Aducanumab and new insights into viral links and sleep-based protein clearance, are being matched by systemic reforms to shift 50% of care to home settings and address the disproportionate burden on female caregivers. Despite these strides, experts emphasize that reducing reliance on acute hospitalization and mitigating risks through lifestyle interventions like blood pressure control and social engagement remain critical to curbing the disease's demographic and economic impact.